All 56 Enrolled Subjects Have Been Through Their Activation Visit Firming Up Study Timeline
News Room
Proven Med Tech Leader with an Established Track Record of Commercial Success and Optimizing Shareho...
Company Remains on Schedule for PMA Submission to FDA White Bear Lake, Minnesota--(Newsfile Corp. - ...
Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to ...
First Cochlear Implant Company to Announce Completed Enrollment of a U.S. Pivotal Clinical Trial for...
White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2026) - Envoy Medical® Inc. (NASDAQ: COCH...
White Bear Lake, Minnesota--(Newsfile Corp. - February 23, 2026) - Envoy Medical® Inc. (NASDAQ: COCH...
Financing was led by new investor and top-tier healthcare fund Nantahala Capital and longtime Envoy ...
45 of 56 Patients Implanted; Enrollment Completion Anticipated by End of March
$30.0 million upfront with up to an additional $48.0 million of potential aggregate gross proceeds u...
*The materials and resources presented are intended to be an educational resource for general purposes only. They are not intended to constitute medical or business advice or in any way replace the independent medical judgment of a trained and licensed physician. Each person’s situation is unique and risks, outcomes, experience and results may vary. CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by federal (or United States) law to investigational use.










